je.st
news
Bluebird Bio: Transforming The Gene Therapy Landscape In Rare Diseases
2015-05-30 04:35:43| Trucking - Topix.net
Initial SCD data is due in June and significant upside remains if LentiGlobin proves to make a difference in patient lives. The company is in an excellent fundamental position and is well positioned to progress towards late-stage and regulatory submissions.
Tags: rare
bio
therapy
gene
Category:Transportation and Logistics
Latest from this category |
All news |
||||||||||||||||||
|
|||||||||||||||||||